MedTrace Logo

Eon™ FR Clinical Study Protocol 1064

NCT03898830 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2020-05-19

No results posted yet for this study

Summary

This study evaluates the treatment of subjects with the eon™ FR 1064 nm device in a single session to thermally induce apoptosis in adipose tissue.

Conditions

  • Fat Disorder

Interventions

DEVICE

eon™ FR 1064 nm device

The subject treatment area - abdomen, was treated with the 1064 nm wavelength laser.

Sponsors & Collaborators

  • Dominion Aesthetic Technologies, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-08
Primary Completion
2019-03-22
Completion
2019-03-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03898830 on ClinicalTrials.gov